Current concepts regarding use of DMPA

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 47, Issue 9 SUPPL., 2002, Pages 785-789

  Kaunitz, Andrew M ^a  

^a UNIVERSITY OF FLORIDA HEALTH SCIENCE CENTER   (United States)

Author keywords

Contraceptive agents, female; Depo medroxyprogesterone acetate; DMPA; Injectable contraceptives

Indexed keywords

ESTROGEN; GESTAGEN; MEDROXYPROGESTERONE ACETATE; ORAL CONTRACEPTIVE AGENT;

AFFECTIVE NEUROSIS; AMENORRHEA; ARTERY THROMBOSIS; BODY WEIGHT DISORDER; CONFERENCE PAPER; CONTRACEPTION; DEPRESSION; DISEASE EXACERBATION; DRUG EFFICACY; FEMALE; HUMAN; LACTATION DISORDER; MENSTRUATION DISORDER; MIGRAINE; PATIENT COUNSELING; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; UNITED STATES; VEIN THROMBOSIS;

CONTRACEPTION; CONTRACEPTIVE AGENTS, FEMALE; CONTROLLED CLINICAL TRIALS; COUNSELING; DELAYED-ACTION PREPARATIONS; FEMALE; HUMANS; INJECTIONS, INTRAMUSCULAR; MEDROXYPROGESTERONE 17-ACETATE; PATIENT SATISFACTION; UNITED STATES; WOMEN'S HEALTH;

EID: 0036745787     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (22)

1. United Nations Population Fund: Contraceptive Use and Commodity Costs in Developing Countries, 1994-2005. New York, UNPF, 1994 (http://www.unfpa.org/publications/technical.htm)
2. Kaunitz AM: Injectable contraception: New and existing options. Obstet Gynecol Clin North Am 2000;27:741-780
3. Mishell DR: Pharmacokinetics of depot medroxyprogesterone acetate contraception. J Reprod Med (suppl) 1996;42:381-390
4. Trussell J, Hatcher RA, Cates W, et al: A guide to interpreting contraceptive efficacy studies. Obstet Gynecol 1990;76: 558-567
5. Schwallie PC, Assenzo R: Contraceptive use: Efficacy study utilizing medroxyprogesterone acetate administered as an intramuscular injection once every 90 days. Fertil Steril 1973;24:331-339
6. Kirton KT, Cornette JC: Return of ovulatory cyclicity following an intramuscular injection of medroxyprogesterone acetate. Contraception 1974;10:39-45
7. The Use of Hormonal Contraception in Women with Coexisting Medical Conditions. Washington, DC, American College of Obstetricians and Gynecologists, Practice Bulletin No. 18, July 2000
8. Speroff L, Darney PH (editors): A Clinical Guide for Contraception. Third edition. Philadelphia, Lippincott Williams & Wilkins, 2001
9. Mainwaring R, Hales HA, Stevenson K, et al: Metabolic parameter, bleeding, and weight changes in US women using progestin only contraceptives. Contraception 1995;51:149-153
10. Ortiz A, Hiroi M, Stanczyk FZ, et al: Serum medroxyprogesterone acetate (MPA) concentrations and ovarian function following intramuscular injection of depo-MPA. J Clin Endocrinol Metab 1977;44:32-38
11. Schwallie PC, Assenzo JR: The effect of depo-medroxyprogesterone acetate on pituitary and ovarian function, and the return of fertility following its discontinuation: A review. Contraception 1974;10:181-184
12. Lei ZW, Wu SC, Garceau RJ, et al: Effect of pretreatment counseling on discontinuation rates in Chinese women given depot-medroxyprogesterone acetate for contraception. Contraception 1996;53:357-361
13. Canto de Cetina TE, Canto P, Ordonez Luna M: Effect of counseling to improve compliance in Mexican women receiving depot-medroxyprogesterone acetate. Contraception 2001;63:143-146
14. Westoff C, Wieland D, Tiezzi L: Depression in users of depot-medroxyprogesterone acetate. Contraception 1995;51:351-354
15. Civic D, Scholes D, Ischikawa L, et al: Depressive symptoms in users and non-users of depot medroxyprogesterone acetate. Contraception 2000;61:385-390
16. Westhoff C, Truman C, Kalmuss D, et al: Depressive symptoms and Depo-Provera. Contraception 1998;57:237-249
17. Pelkman CL, Chow M, Heinbach RA, et al: Short-term effects of a progestational contraceptive drug on food intake, resting energy expenditure, and body weight in young women. Am J Clin Nutr 2001;73:19-26
18. Moore LL, Valuck R, McDougal C, et al: A comparative study of one-year weight gain among users of medroxyprogesterone acetate, levonorgestral implants, and oral contraceptives. Contraception 1995;52:215-220
19. Risser WL, Gefter LR, Barratt MS, et al: Weight change in adolescents who used hormonal contraception. J Adolesc Med 1999;24:433-436
20. Physicians Desk Reference. Fifty-sixth edition. Montvale, New Jersey, 2001, pp 2798-2801
21. Abma JC, Chandra A, Mosher WD, et al: Fertility, family planning, and women's health: New data from the 1995 National Survey of Family Growth, Vital Health Stat 1997;23:1-114
22. Potter L, Oakley D, de Leon-Wong E, et al: Measuring compliance among oral contraceptive users. Fam Plann Perspect 1996;28:154-158